相关实验视频
Updated: Jun 23, 2025

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.7K
对跨越流行病阶段连续性的心血管临床试验的统计考虑
Roseann White1, Peter Lam2, Nelson Lu3
1Your 3rd Opinion, 5515 New Rise Ct, Chapel Hill, NC 27516, United States of America.
概括
PAIINTERS工作组在心血管设备试验中解决了流行病的挑战. 本研究提供了统计策略,以减轻在公共卫生危机期间的干预研究中的偏见,变异性和缺失数据.
科学领域:
- 心血管医学 心血管医学
- 临床试验方法论 临床试验方法论
- 公共卫生 公共卫生
背景情况:
- 由于COVID-19的流行,人类受试者研究需要新的指导方针.
- 心血管干预器械试验面临着独特的操作和统计挑战.
- 现有的流行病指南需要适应特定的临床试验应用.
研究的目的:
- 为了解决大流行对心血管干预器械试验的统计影响.
- 建议减轻偏差,变异性,缺失数据和受流行病阶段影响的试验中的功率的缓解策略.
- 为心血管临床研究的研究人员和专业人士提供实际指导.
主要方法:
- 在INTERrventional设备研究 (PAIINTERS) 工作组中形成流行病影响.
- 分析潜在的统计问题,包括偏见,变化,缺失数据和研究功率.
- 为单臂试验 (SAT) 和随机对照试验 (RCT) 制定实际缓解策略.
主要成果:
- 在大流行期间进行心血管干预试验时确定了重大统计挑战.
- 详细的潜在偏差和由波动的流行病条件引入的变化.
- 提出了可行的策略,以尽量减少流行病相关干扰对研究完整性和功率的影响.
结论:
- PAIINTERS Part II报告提供了关键的见解,了解如何在流行病期间管理心血管设备试验中的统计复杂性.
- 建议的缓解策略对于维持干预研究的有效性和可靠性至关重要.
- 这项工作是公共卫生紧急情况期间导航研究的重要资源.
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Assumptions of Survival Analysis
121
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
121
Hazard Ratio
111
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
111
Introduction to Epidemiology
706
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
706
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177

